Filtros : "Indexado na Base de Dados Chemical Abstracts" "Indexado na Base de Dados Biobase" Limpar

Filtros



Refine with date range


  • Source: Vaccine. Unidade: FM

    Subjects: VACINAS, REVISÃO SISTEMÁTICA, CUSTO ECONÔMICO, IMUNIZIÇÃO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LOZE, Priscilla Magalhaes et al. Vaccines are different: A systematic review of budget impact analyses of vaccines. Vaccine, v. 35, n. 21, p. 2781-2793, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2017.03.088. Acesso em: 02 nov. 2024.
    • APA

      Loze, P. M., Nasciben, L. B., Sartori, A. M. C., Itria, A., Novaes, H. M. D., & Soárez, P. C. de. (2017). Vaccines are different: A systematic review of budget impact analyses of vaccines. Vaccine, 35( 21), 2781-2793. doi:10.1016/j.vaccine.2017.03.088
    • NLM

      Loze PM, Nasciben LB, Sartori AMC, Itria A, Novaes HMD, Soárez PC de. Vaccines are different: A systematic review of budget impact analyses of vaccines [Internet]. Vaccine. 2017 ; 35( 21): 2781-2793.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2017.03.088
    • Vancouver

      Loze PM, Nasciben LB, Sartori AMC, Itria A, Novaes HMD, Soárez PC de. Vaccines are different: A systematic review of budget impact analyses of vaccines [Internet]. Vaccine. 2017 ; 35( 21): 2781-2793.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2017.03.088
  • Source: Vaccine. Unidade: FM

    Subjects: HIV, VACINAS VIRAIS, HEPATITE B, PROMOÇÃO DA SAÚDE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LARA, Amanda Nazareth et al. Long-term protection after hepatitis B vaccination in people living with HIV. Vaccine, v. 35, n. 33, p. 4155-4161, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2017.06.040. Acesso em: 02 nov. 2024.
    • APA

      Lara, A. N., Sartori, A. M., Oliveira Fonseca, M., & Lopes, M. H. (2017). Long-term protection after hepatitis B vaccination in people living with HIV. Vaccine, 35( 33), 4155-4161. doi:10.1016/j.vaccine.2017.06.040
    • NLM

      Lara AN, Sartori AM, Oliveira Fonseca M, Lopes MH. Long-term protection after hepatitis B vaccination in people living with HIV [Internet]. Vaccine. 2017 ; 35( 33): 4155-4161.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2017.06.040
    • Vancouver

      Lara AN, Sartori AM, Oliveira Fonseca M, Lopes MH. Long-term protection after hepatitis B vaccination in people living with HIV [Internet]. Vaccine. 2017 ; 35( 33): 4155-4161.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2017.06.040
  • Source: Vaccine. Unidade: FM

    Subjects: GRAVIDEZ, PREVENÇÃO DE DOENÇAS, PROMOÇÃO DA SAÚDE, CUSTOS DOS CUIDADOS DE SAÚDE, BRASIL

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SARTORI, Ana Marli Christovam et al. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil. Vaccine, v. 34, n. 13, p. 1531-1539, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2016.02.026. Acesso em: 02 nov. 2024.
    • APA

      Sartori, A. M. C., Soárez, P. C. de, Fernandes, E. G., Gryninger, L. C. F., Viscondi, J. Y. K., & Novaes, H. M. D. (2016). Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil. Vaccine, 34( 13), 1531-1539. doi:10.1016/j.vaccine.2016.02.026
    • NLM

      Sartori AMC, Soárez PC de, Fernandes EG, Gryninger LCF, Viscondi JYK, Novaes HMD. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil [Internet]. Vaccine. 2016 ; 34( 13): 1531-1539.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2016.02.026
    • Vancouver

      Sartori AMC, Soárez PC de, Fernandes EG, Gryninger LCF, Viscondi JYK, Novaes HMD. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil [Internet]. Vaccine. 2016 ; 34( 13): 1531-1539.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2016.02.026
  • Source: Vaccine. Unidade: FM

    Subjects: ZIKA VÍRUS, VETORES, VÍRUS DA DENGUE, TRANSMISSÃO DE DOENÇAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PALACIOS, Ricardo e POLAND, Gregory A. e KALIL, Jorge. Another emerging arbovirus, another emerging vaccine: Targeting Zika virus [Editorial]. Vaccine. Kidlington: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.vaccine.2016.03.059. Acesso em: 02 nov. 2024. , 2016
    • APA

      Palacios, R., Poland, G. A., & Kalil, J. (2016). Another emerging arbovirus, another emerging vaccine: Targeting Zika virus [Editorial]. Vaccine. Kidlington: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.vaccine.2016.03.059
    • NLM

      Palacios R, Poland GA, Kalil J. Another emerging arbovirus, another emerging vaccine: Targeting Zika virus [Editorial] [Internet]. Vaccine. 2016 ; 34( 20): 2291-2293.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2016.03.059
    • Vancouver

      Palacios R, Poland GA, Kalil J. Another emerging arbovirus, another emerging vaccine: Targeting Zika virus [Editorial] [Internet]. Vaccine. 2016 ; 34( 20): 2291-2293.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2016.03.059
  • Source: Future Virology. Unidade: ICB

    Subjects: MICROBIOLOGIA, DENGUE ANIMAL, MODELOS ANIMAIS, CAMUNDONGOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AMORIM, Jaime Henrique et al. Dengue virus models based on mice as experimental hosts. Future Virology, v. 10, n. 7, p. 835-844, 2015Tradução . . Disponível em: https://doi.org/10.2217/fvl.15.48. Acesso em: 02 nov. 2024.
    • APA

      Amorim, J. H., Bizerra, R., Alves, R. P. dos S., Fabris, D. L. N., & Ferreira, L. C. de S. (2015). Dengue virus models based on mice as experimental hosts. Future Virology, 10( 7), 835-844. doi:10.2217/fvl.15.48
    • NLM

      Amorim JH, Bizerra R, Alves RP dos S, Fabris DLN, Ferreira LC de S. Dengue virus models based on mice as experimental hosts [Internet]. Future Virology. 2015 ; 10( 7): 835-844.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2217/fvl.15.48
    • Vancouver

      Amorim JH, Bizerra R, Alves RP dos S, Fabris DLN, Ferreira LC de S. Dengue virus models based on mice as experimental hosts [Internet]. Future Virology. 2015 ; 10( 7): 835-844.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2217/fvl.15.48
  • Source: Vaccine. Unidade: FM

    Subjects: IMUNOLOGIA, VACINAS, FEBRE REUMÁTICA, STREPTOCOCCUS PYOGENES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DE AMICIS, Karine M. et al. Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes. Vaccine, v. 32, n. 32, p. 4104-4110, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2013.08.043. Acesso em: 02 nov. 2024.
    • APA

      De Amicis, K. M., Barros, S. F. de, Alencar, R. E., Postól, E., Martins, C. de O., Arcuri, H. A., et al. (2014). Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes. Vaccine, 32( 32), 4104-4110. doi:10.1016/j.vaccine.2013.08.043
    • NLM

      De Amicis KM, Barros SF de, Alencar RE, Postól E, Martins C de O, Arcuri HA, Goulart C, Kalil J, Guilherme L. Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes [Internet]. Vaccine. 2014 ; 32( 32): 4104-4110.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2013.08.043
    • Vancouver

      De Amicis KM, Barros SF de, Alencar RE, Postól E, Martins C de O, Arcuri HA, Goulart C, Kalil J, Guilherme L. Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes [Internet]. Vaccine. 2014 ; 32( 32): 4104-4110.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2013.08.043
  • Source: Vaccine. Unidades: HU, FM, IMT, FSP

    Subjects: TRIAGEM, PLACEBOS, VACINAS, MÉTODO DUPLO-CEGO, INFLUENZA (IMUNOLOGIA)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PRECIOSO, Alexander R. et al. A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems. Vaccine, v. 29, n. 48, p. 8974-8981, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2011.09.040. Acesso em: 02 nov. 2024.
    • APA

      Precioso, A. R., Miraglia, J. L., Campos, L. M. A., Goulart, A. C., Timenetsky, M. do C. S. .T., Cardoso, M. R. A., et al. (2011). A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems. Vaccine, 29( 48), 8974-8981. doi:10.1016/j.vaccine.2011.09.040
    • NLM

      Precioso AR, Miraglia JL, Campos LMA, Goulart AC, Timenetsky M do CS .T, Cardoso MRA, Luna EJ de A, Mondini G, Guedes J da S, Raw I. A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems [Internet]. Vaccine. 2011 ; 29( 48): 8974-8981.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2011.09.040
    • Vancouver

      Precioso AR, Miraglia JL, Campos LMA, Goulart AC, Timenetsky M do CS .T, Cardoso MRA, Luna EJ de A, Mondini G, Guedes J da S, Raw I. A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems [Internet]. Vaccine. 2011 ; 29( 48): 8974-8981.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2011.09.040
  • Source: Vaccine. Unidade: FM

    Subjects: CAMUNDONGOS, INFECÇÕES ESTREPTOCÓCICAS, HISTOPATOLOGIA ANIMAL, VACINAS VIRAIS, INFLAMAÇÃO

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GUERINO, Milton T. et al. HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate. Vaccine, v. 29, n. 46, p. 8250-8256, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2011.08.113. Acesso em: 02 nov. 2024.
    • APA

      Guerino, M. T., Postol, E., Demarchi, L. M. F., Martins, C. O., Mundel, L. R., Kalil, J., & Guilherme , L. (2011). HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate. Vaccine, 29( 46), 8250-8256. doi:10.1016/j.vaccine.2011.08.113
    • NLM

      Guerino MT, Postol E, Demarchi LMF, Martins CO, Mundel LR, Kalil J, Guilherme L. HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate [Internet]. Vaccine. 2011 ; 29( 46): 8250-8256.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2011.08.113
    • Vancouver

      Guerino MT, Postol E, Demarchi LMF, Martins CO, Mundel LR, Kalil J, Guilherme L. HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate [Internet]. Vaccine. 2011 ; 29( 46): 8250-8256.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2011.08.113
  • Source: Vaccine. Unidade: FM

    Subjects: VACINAS VIRAIS, INFLUENZA (IMUNOLOGIA), ANEMIA (FISIOPATOLOGIA)

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Alessandra R. et al. Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia. Vaccine, v. 28, n. 4, p. 1117-1120, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2009.05.046. Acesso em: 02 nov. 2024.
    • APA

      Souza, A. R., Braga, J. A. P., Paiva, T. M. de, Loggetto, S. R., Azevedo, R. S., & Weckx, L. Y. (2010). Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia. Vaccine, 28( 4), 1117-1120. doi:10.1016/j.vaccine.2009.05.046
    • NLM

      Souza AR, Braga JAP, Paiva TM de, Loggetto SR, Azevedo RS, Weckx LY. Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia [Internet]. Vaccine. 2010 ; 28( 4): 1117-1120.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2009.05.046
    • Vancouver

      Souza AR, Braga JAP, Paiva TM de, Loggetto SR, Azevedo RS, Weckx LY. Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia [Internet]. Vaccine. 2010 ; 28( 4): 1117-1120.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2009.05.046
  • Source: Cell Biology International. Unidade: ICB

    Assunto: HISTOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AMARAL, Jônatas Bussador do e URABAYASHI, Marcel Shiniti e MACHADO-SANTELLI, Glaúcia Maria. Cell death and lumen formation in spheroids of MCF-7 cells. Cell Biology International, n. 3, p. 267-274, 2010Tradução . . Disponível em: https://doi.org/10.1042/cbi20090024. Acesso em: 02 nov. 2024.
    • APA

      Amaral, J. B. do, Urabayashi, M. S., & Machado-Santelli, G. M. (2010). Cell death and lumen formation in spheroids of MCF-7 cells. Cell Biology International, ( 3), 267-274. doi:10.1042/cbi20090024
    • NLM

      Amaral JB do, Urabayashi MS, Machado-Santelli GM. Cell death and lumen formation in spheroids of MCF-7 cells [Internet]. Cell Biology International. 2010 ;( 3): 267-274.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1042/cbi20090024
    • Vancouver

      Amaral JB do, Urabayashi MS, Machado-Santelli GM. Cell death and lumen formation in spheroids of MCF-7 cells [Internet]. Cell Biology International. 2010 ;( 3): 267-274.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1042/cbi20090024
  • Source: Vaccine. Unidades: ICB, FCF

    Assunto: MICROBIOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BARGIERI, Daniel Youssef et al. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium. Vaccine, v. 28, n. 16, p. 2818-2826, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2010.02.004. Acesso em: 02 nov. 2024.
    • APA

      Bargieri, D. Y., Leite, J. A., Lopes, S. C. P., Sbrogio-Almeida, M. E., Braga, C. J. M., Ferreira, L. C. de S., et al. (2010). Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium. Vaccine, 28( 16), 2818-2826. doi:10.1016/j.vaccine.2010.02.004
    • NLM

      Bargieri DY, Leite JA, Lopes SCP, Sbrogio-Almeida ME, Braga CJM, Ferreira LC de S, Soares I da S, Costa FTM, Rodrigues MM. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium [Internet]. Vaccine. 2010 ; 28( 16): 2818-2826.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2010.02.004
    • Vancouver

      Bargieri DY, Leite JA, Lopes SCP, Sbrogio-Almeida ME, Braga CJM, Ferreira LC de S, Soares I da S, Costa FTM, Rodrigues MM. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium [Internet]. Vaccine. 2010 ; 28( 16): 2818-2826.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2010.02.004
  • Source: Immunopharmacology and Immunotoxicology. Unidade: ICB

    Assunto: IMUNOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ALMEIDA, Ana Carolina de et al. The role of glucocorticoid in SIRPα and SHP-1 gene expression in AIHA patients. Immunopharmacology and Immunotoxicology, v. 31, n. 4, p. 636-640, 2009Tradução . . Disponível em: https://doi.org/10.3109/08923970902939256. Acesso em: 02 nov. 2024.
    • APA

      Almeida, A. C. de, Barbosa, S. M., Barjas-Castro, M. de L., Olalla-Saad, S. T., & Condino Neto, A. (2009). The role of glucocorticoid in SIRPα and SHP-1 gene expression in AIHA patients. Immunopharmacology and Immunotoxicology, 31( 4), 636-640. doi:10.3109/08923970902939256
    • NLM

      Almeida AC de, Barbosa SM, Barjas-Castro M de L, Olalla-Saad ST, Condino Neto A. The role of glucocorticoid in SIRPα and SHP-1 gene expression in AIHA patients [Internet]. Immunopharmacology and Immunotoxicology. 2009 ; 31( 4): 636-640.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3109/08923970902939256
    • Vancouver

      Almeida AC de, Barbosa SM, Barjas-Castro M de L, Olalla-Saad ST, Condino Neto A. The role of glucocorticoid in SIRPα and SHP-1 gene expression in AIHA patients [Internet]. Immunopharmacology and Immunotoxicology. 2009 ; 31( 4): 636-640.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3109/08923970902939256
  • Source: Vaccine. Unidade: FM

    Subjects: VACINAÇÃO (EFEITOS ADVERSOS;IMUNOLOGIA), DIFTERIA, ANTICORPOS, TÉTANO, INFECÇÕES POR HTLV-I, LINFÓCITOS

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BIASUTTI, Claudia e MORAES-PINTO, Maria Isabel e SEGURADO, Aluísio C. Antibody response after vaccination with tetanus and diphtheria toxoids in human T-cell lymphotropic virus type 1 asymptomatic carriers [Carta]. Vaccine. Kidlington: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.sciencedirect.com/science/article/pii/S0264410X08003848. Acesso em: 02 nov. 2024. , 2008
    • APA

      Biasutti, C., Moraes-Pinto, M. I., & Segurado, A. C. (2008). Antibody response after vaccination with tetanus and diphtheria toxoids in human T-cell lymphotropic virus type 1 asymptomatic carriers [Carta]. Vaccine. Kidlington: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.sciencedirect.com/science/article/pii/S0264410X08003848
    • NLM

      Biasutti C, Moraes-Pinto MI, Segurado AC. Antibody response after vaccination with tetanus and diphtheria toxoids in human T-cell lymphotropic virus type 1 asymptomatic carriers [Carta] [Internet]. Vaccine. 2008 ; 26 n. 23 2808-2810.[citado 2024 nov. 02 ] Available from: http://www.sciencedirect.com/science/article/pii/S0264410X08003848
    • Vancouver

      Biasutti C, Moraes-Pinto MI, Segurado AC. Antibody response after vaccination with tetanus and diphtheria toxoids in human T-cell lymphotropic virus type 1 asymptomatic carriers [Carta] [Internet]. Vaccine. 2008 ; 26 n. 23 2808-2810.[citado 2024 nov. 02 ] Available from: http://www.sciencedirect.com/science/article/pii/S0264410X08003848

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024